Bloodbuy Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Bloodbuy's estimated annual revenue is currently $652.5k per year.(i)
  • Bloodbuy's estimated revenue per employee is $72,500

Employee Data

  • Bloodbuy has 9 Employees.(i)
  • Bloodbuy grew their employee count by 0% last year.

Bloodbuy's People

NameTitleEmail/Phone
1
Founder/CEOReveal Email/Phone
2
Director, Customer SuccessReveal Email/Phone
3
Operations ManagerReveal Email/Phone
4
Customer Success ManagerReveal Email/Phone
5
LEAD UX DESIGNERReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.5M12112%N/AN/A
#2
$90.4M49924%N/AN/A
#3
$2M20-23%N/AN/A
#4
$226.8M109446%$261MN/A
#5
$406.7M26008%$26.1MN/A
#6
$14.8M102-61%N/AN/A
#7
$8.6M66-1%N/AN/A
#8
$13.2M91-5%$752.5MN/A
#9
$36.5M2296%N/AN/A
#10
$56.6M31223%N/AN/A
Add Company

What Is Bloodbuy?

Our online network facilitates the efficient distribution of lifesaving biological products. With intuitive web-based tools and unmatched analytics, Bloodbuy enables hospitals and blood products manufacturers to connect in a way never before possible. Our growing network operates in 46 U.S. states and the Caribbean. Bloodbuy has been recognized as an innovator in healthcare information technology by the Harvard Forum on Healthcare Innovation, RAND Corporation, athenahealth, Cardinal Health, and Tech Titans. Our patented cloud-based technology has been featured in WIRED, TechCrunch, Harvard Business Review, Business Insider, NPR Marketplace, Dallas Business Journal, The Boston Globe, and many other notable publications. Bloodbuy is headquartered in Dallas, Texas and financially backed by Premier, Inc. (NASDAQ: PINC), Grifols, S.A. (NASDAQ: GRFS), and Providence St. Joseph Health. LET'S CONNECT: info@bloodbuy.com

keywords:N/A

N/A

Total Funding

9

Number of Employees

$652.5k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9N/AN/A
#2
$0.7M9N/AN/A
#3
$0.7M9N/AN/A
#4
$0.7M9N/AN/A
#5
$0.1M90%$12.8M